DEERFIELD MANAGEMENT COMPANY, L.P. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001009258

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q4 2025 · 145 positions · Total reported value $7.10B · Top-10 concentration 54.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 38.6% · 10 new · 12 cut · 12 exited

Active Share (vs S&P 500): 99.6% · vs QQQ: 99.9% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +17.1% · vs SPY +2.2% · Prev Value $7.59B — last quarter positions weighted by this quarter price moves · ranking

In its Q4 2025 13F filing, DEERFIELD MANAGEMENT COMPANY, L.P. disclosed 145 equity positions with a combined reported value of $7.10B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 54.0% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2025 were NUVL ($1.74B), COGT ($321.24M), PRAX ($266.25M). By sector, the heaviest allocations are Health Care 69.5%, Technology 1.1%. Versus the prior quarter, allocation shifted toward Health Care (+5.6pp) and away from Other (-5.2pp).

Versus the prior quarter, DEERFIELD MANAGEMENT COMPANY, L.P. opened 10 new positions, trimmed 12 and fully exited 12, a turnover rate of 38.6% of positions. The portfolio's overlap with the prior quarter was 65% of names.

The largest new positions opened in Q4 2025 were STOK ($57.88M), LNTH ($55.10M), BLTE ($37.40M).

Of the 12 positions fully exited versus the prior quarter, the largest were MRUS ($286.87M), BMY ($105.43M), MRK ($86.45M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2025)

  • STOK STOKE THERAPEUTICS INC · $57.88M
  • LNTH LANTHEUS HLDGS INC · $55.10M
  • BLTE BELITE BIO INC · $37.40M
  • TNGX TANGO THERAPEUTICS INC · $25.76M
  • CMPX COMPASS THERAPEUTICS INC · $19.36M
  • KYTX KYVERNA THERAPEUTICS INC · $18.80M
  • MDLN MEDLINE INC · $10.92M
  • VEEV VEEVA SYS INC · $3.95M

Fully Exited (vs previous quarter)

  • MRUS MERUS N V · prev qtr: $286.87M
  • BMY BRISTOL-MYERS SQUIBB CO · prev qtr: $105.43M
  • MRK MERCK & CO. INC. · prev qtr: $86.45M
  • PFE PFIZER INC · prev qtr: $84.18M · history
  • INSM INSMED INC · prev qtr: $67.83M
  • ZBIO ZENAS BIOPHARMA INC COM · prev qtr: $34.70M · history
  • DCGO DOCGO INC · prev qtr: $6.29M
  • SI SHOULDER INNOVATIONS INC · prev qtr: $6.06M

Insider Transactions (Form 4)

Latest DEERFIELD MANAGEMENT COMPANY, L.P. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-07-15 D Nuvalent, Inc. 3,444 $124.00 SEC filing
2026-07-15 U Nuvalent, Inc. 5,146 $124.00 SEC filing
2026-07-15 D Nuvalent, Inc. 650,000 $124.00 SEC filing
2026-07-15 D Nuvalent, Inc. 8,299,225 $124.00 SEC filing
2026-06-16 Award Nuvalent, Inc. 3,444 — SEC filing
2026-06-11 Conversion Parabilis Medicines, Inc. 407,132 — SEC filing
2026-06-11 Conversion Parabilis Medicines, Inc. 260,992 — SEC filing
2026-06-11 Conversion Parabilis Medicines, Inc. 149,238 — SEC filing

All insider transactions →

Fund Profile

Deerfield Management Company, L.P. is a New York-based hedge fund founded by Marianne and James Chadwin, known for its quantitative and fundamental research approach focused primarily on healthcare and biotechnology investments.

Investment Approach

Combines quantitative analysis with fundamental research

Specializes in healthcare and biotechnology sectors

Utilizes both public and private investment strategies

Asset Classes & Strategy

Primarily focused on long/short equity positions

Specializes in healthcare and biotechnology investments

Also invests in other sectors with strong fundamental research

Key Personnel

Marianne Chadwin (Co-founder)

James Chadwin (Co-founder)

Team of experienced portfolio managers and researchers

AUM & Performance

Manages approximately $19.1 billion in assets under management

Performance data not publicly disclosed

All information is based on publicly available SEC filings and company disclosures.

Sector Allocation

Health Care 69.5%
Technology 1.1%
Materials 0.0%
Financials 0.0%
Other 27.4%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 17.25M $1.74B 24.45%
24.45%
Reduce
2 9.04M $321.24M 4.53%
4.53%
Hold
3 903.35K $266.25M 3.75%
3.75%
Add
4 6.45M $265.34M 3.74%
3.74%
Reduce
5 20.21M $251.57M 3.54%
3.54%
Reduce
6 2.89M $230.56M 3.25%
3.25%
Reduce
7 425.99K $207.57M 2.92%
2.92%
Hold
8 4.06M $205.58M 2.90%
2.90%
Add
9 70.00M $180.71M 2.55%
2.55%
Hold
10 1.71M $170.95M 2.41%
2.41%
Add
11 1.18M $167.98M 2.37%
2.37%
Hold
12 4.16M $146.10M 2.06%
2.06%
Reduce
13 1.51M $138.89M 1.96%
1.96%
Add
14 5.93M $128.96M 1.82%
1.82%
Add
15 11.64M $125.56M 1.77%
1.77%
Hold
16 3.39M $121.74M 1.72%
1.72%
Reduce
17 1.83M $121.69M 1.72%
1.72%
Add
18 30.61M $116.61M 1.64%
1.64%
Hold
19 4.91M $114.63M 1.61%
1.61%
Reduce
20 11.48M $114.32M 1.61%
1.61%
Hold
21 14.34M $111.86M 1.58%
1.58%
Add
22 60.00M $95.33M 1.34%
1.34%
Hold
23 7.50M $87.42M 1.23%
1.23%
Hold
24 3.13M $86.75M 1.22%
1.22%
Add
25 13.57M $81.82M 1.15%
1.15%
Add
26 2.15M $74.43M 1.05%
1.05%
Hold
27 7.81M $68.79M 0.97%
0.97%
Add
28 226.07K $68.50M 0.96%
0.96%
Hold
29 72.69M $64.69M 0.91%
0.91%
Add
30 4.52M $64.14M 0.90%
0.90%
Add
31 4.89M $61.17M 0.86%
0.86%
Hold
32 1.82M $57.88M 0.81%
0.81%
New
33 828.00K $55.10M 0.78%
0.78%
New
34 767.99K $53.41M 0.75%
0.75%
Add
35 2.28M $49.51M 0.70%
0.70%
Reduce
36 4.75M $43.77M 0.62%
0.62%
Hold
37 561.17K $43.66M 0.61%
0.61%
Reduce
38 2.19M $41.28M 0.58%
0.58%
Hold
39 511.16K $40.59M 0.57%
0.57%
Reduce
40 970.59K $39.93M 0.56%
0.56%
Hold
41 34.28M $39.73M 0.56%
0.56%
Hold
42 233.81K $37.40M 0.53%
0.53%
New
43 3.72M $34.70M 0.49%
0.49%
Reduce
44 2.00M $33.82M 0.48%
0.48%
Add
45 2.75M $32.69M 0.46%
0.46%
Add
46 726.00K $30.56M 0.43%
0.43%
Hold
47 1.00M $29.49M 0.41%
0.41%
Hold
48 938.31K $28.59M 0.40%
0.40%
Reduce
49 354.00K $27.39M 0.39%
0.39%
Hold
50 67.94K $27.01M 0.38%
0.38%
Hold

FAQ

What did DEERFIELD MANAGEMENT COMPANY, L.P. buy in 2025-Q4?

In its 2025-Q4 13F filing, DEERFIELD MANAGEMENT COMPANY, L.P. reported 145 equity positions worth $7.10B in aggregate; its largest disclosed positions were NUVL ($1.74B), COGT ($321.24M), PRAX ($266.25M).

How large is DEERFIELD MANAGEMENT COMPANY, L.P.'s portfolio?

DEERFIELD MANAGEMENT COMPANY, L.P. reported $7.10B of long equity holdings across 145 positions as of 2025-Q4. Top-10 holdings account for 54.0% of reported value.

What is DEERFIELD MANAGEMENT COMPANY, L.P.'s investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/deerfield-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →